This company has been marked as potentially delisted and may not be actively trading. Aileron Therapeutics (ALRN) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Aileron Therapeutics (NASDAQ:ALRN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$896.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$21.57K Get ALRN Insider Trade Alerts Want to know when executives and insiders are buying or selling Aileron Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALRN Insider Buying and Selling by Quarter Aileron Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/5/2024James Brian WindsorCEOBuy400$2.24$896.00 6/17/2024Of Texas/Texas Am I UniversityMajor ShareholderSell4,707$3.25$15,297.75 6/14/2024Of Texas/Texas Am I UniversityMajor ShareholderSell1,900$3.30$6,270.00 (Data available from 1/1/2013 forward) ALRN Insider Trading Activity - Frequently Asked Questions Who is on Aileron Therapeutics's Insider Roster? The list of insiders at Aileron Therapeutics includes James Brian Windsor, and Of Texas/Texas Am I University. Learn more on insiders at ALRN. What percentage of Aileron Therapeutics stock is owned by insiders? 5.10% of Aileron Therapeutics stock is owned by insiders. Learn more on ALRN's insider holdings. Which Aileron Therapeutics insiders have been buying company stock? The following insider purchased ALRN shares in the last 24 months: James Brian Windsor ($11,653.97). How much insider buying is happening at Aileron Therapeutics? Insiders have purchased a total of 5,701 ALRN shares in the last 24 months for a total of $11,653.97 bought. Which Aileron Therapeutics insiders have been selling company stock? The following insider sold ALRN shares in the last 24 months: Of Texas/Texas Am I University ($248,684.90). How much insider selling is happening at Aileron Therapeutics? Insiders have sold a total of 64,618 Aileron Therapeutics shares in the last 24 months for a total of $248,684.90 sold. Aileron Therapeutics Key ExecutivesDr. James Brian Windsor Ph.D. (Age 58)CEO, President & Director Compensation: $715.92k More Insider Trading Tools from MarketBeat Related Companies ESPR Insider Transactions VYGR Insider Transactions DERM Insider Transactions DMAC Insider Transactions FDMT Insider Transactions INMB Insider Transactions PBYI Insider Transactions NLTX Insider Transactions SLS Insider Transactions ALTS Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders Bought This page (NASDAQ:ALRN) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aileron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aileron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
